Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 101kWORD 21k
7 November 2018
E-004187/2018(ASW)
Answer given by Ms Bieńkowska on behalf of the European Commission
Question reference: E-004187/2018

On November 2016, the Commission adopted a notice(1) aiming at clarifying that plants exclusively obtained by essential biological processes are not patentable subject matter. The European Patent Organisation (EPO) whilst not an EU organisation, decided to align its implementing rules with the notice, effective as of July 2017.

The Commission does not comment the merits of specific cases decided by the EPO, in particular when appeal procedures within the European Patent Office are still ongoing. However, the Commission is closely monitoring developments in this fast-evolving sector, with Member States and relevant stakeholders.

(1)Commission Notice on certain Articles of Directive 98/44/EC of the European Parliament and of the Council on the legal protection of biotechnological inventions (2016/C 411/03).

Last updated: 8 November 2018Legal notice